TRex Bio Files For IPO As Collaboration With Eli Lilly Deepens
AI Summary
TRex Bio has filed for an initial public offering (IPO), signaling growth and deepening collaboration with pharmaceutical giant Eli Lilly. This move highlights increasing investment and deal activity in the biotech sector.